Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

S

SLS

SELLAS Life Sciences Group Inc

11.11

Aug 04 • 10:11 AM ET -0.11 (-0.98%)

Healthcare Biotechnology USA Mid NASD

Peers: IDYA TNGX CGON RCUS NUVL BMRN KYMR RYTM INCY KRYS

| Held by: VTI XBI IWM VXF IWO VTWO VHT IWC VTWG LABU

Scroll to Statements

Index	RUT
Market Cap	2.07B
Enterprise Value	1.96B
Income	-29.46M
Sales	0.00M
Book/sh	0.59
Cash/sh	0.58
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Mar 24, 2011
Dividend Gr. 3/5Y	- -
Payout	-
Employees	13
IPO	Mar 12, 2008

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	18.76
P/C	19.28
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	17.22
Current Ratio	17.22
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.23
EPS next Y	-0.12
EPS next Q	-0.04
EPS this Y	16.00%
EPS next Y	40.48%
EPS next 5Y	-
EPS past 3/5Y	51.28% 34.92%
Sales past 3/5Y	- -
EPS Y/Y TTM	41.60%
Sales Y/Y TTM	-
EPS Q/Q	26.44%
Sales Q/Q	-
Earnings	May 12 AMC
EPS/Sales Surpr.	16.67% -

Insider Own	1.21%
Insider Trans	0.00%
Inst Own	30.47%
Inst Trans	9.44%
ROA	-39.50%
ROE	-43.58%
ROIC	-27.35%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-6.85%
SMA50	4.93%
SMA200	102.28%
Trades

Shs Outstand	186.03M
Shs Float	183.79M
Short Float	30.08%
Short Ratio	5.73
Short Interest	55.28M
52W High	15.88 -30.02%
52W Low	1.39 699.28%
Volatility	10.30% 11.38%
ATR (14)	1.24
RSI (14)	49.02
Beta	2.50
Rel Volume	0.82
Avg Volume	9.65M
Volume	1,180,971

Perf Week	10.11%
Perf Month	-20.30%
Perf Quarter	121.31%
Perf Half Y	179.85%
Perf YTD	194.69%
Perf Year	598.74%
Perf 3Y	626.14%
Perf 5Y	26.83%
Perf 10Y	-99.92%
Recom	1.00
Target Price	27.50
Prev Close	11.22
Price	11.11
Change	-0.98%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)